|  | Cancer | Skin Cancer

Aldara Cream and Skin Cancer: What You Need to Know

Regulatory Status

Aldara (imiquimod 5% cream) is FDA-approved for actinic keratosis, superficial basal cell carcinoma (sBCC), and external genital/perianal warts. It is not approved for other skin cancers (e.g., nodular BCC, squamous cell carcinoma, melanoma), though off-label use occurs.

Mechanism

Immune response modifier → activates TLR7 → cytokine release (IFN-α, TNF-α, IL-12) → local immune attack on abnormal cells.

Typical Regimen (sBCC)

Apply once daily, 5 days/week, for 6 weeks (up to 12 weeks if needed). Use under clinician supervision.

Side Effects

Local: erythema, erosion, itching, burning, scabbing, flu-like symptoms. Usually resolve after treatment.

Contraindications

  • Known hypersensitivity.
  • Pregnancy/breastfeeding (insufficient data).

Bottom Line

Discuss with your dermatologist whether imiquimod is appropriate for your specific lesion type and location.

Skin Cancer - Related Articles